News | January 21, 2026
Senores Pharmaceuticals reports stellar Q3 FY26 growth; PAT surges 105%
In Q3 FY26, Senores posted consolidated revenue of Rs. 175 crore, up 64% year-on-year.
In Q3 FY26, Senores posted consolidated revenue of Rs. 175 crore, up 64% year-on-year.
The product will be marketed by Dr. Reddy's Laboratories Inc.
Senores Pharmaceuticals is poised to accelerate its presence in the Asia-Pacific region
Senores Pharmaceuticals (SPI) acquired 51% stake in Zoraya Pharmaceuticals
The acquired ANDAs represent a market opportunity of about US$ 38 million in the USA
Havix is a US based company engaged in the business of developing, manufacturing and supplying of various finished formulations
Topiramate is indicated as a treatment of epilepsy and migraine
Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
Havix was incorporated under the laws of the State of Delaware on February 17, 2015
The basket acquired, comprises of 13 ANDAs, which are approved by the USFDA and 1 ANDA, which is pending approval from the USFDA
Subscribe To Our Newsletter & Stay Updated
